- Home
- NVAX vs SCS Comparison
NVAX vs SCS Comparison
Compare NVAX & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SCS
- Stock Information
- Founded
- NVAX 1987
- SCS 1912
- Country
- NVAX United States
- SCS United States
- Employees
- NVAX N/A
- SCS N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SCS Office Equipment/Supplies/Services
- Sector
- NVAX Health Care
- SCS Consumer Discretionary
- Exchange
- NVAX Nasdaq
- SCS Nasdaq
- Market Cap
- NVAX 1.4B
- SCS 1.3B
- IPO Year
- NVAX 1995
- SCS 1998
- Fundamental
- Price
- NVAX $8.38
- SCS $11.32
- Analyst Decision
- NVAX Buy
- SCS Strong Buy
- Analyst Count
- NVAX 6
- SCS 2
- Target Price
- NVAX $17.83
- SCS $17.00
- AVG Volume (30 Days)
- NVAX 4.8M
- SCS 543.3K
- Earning Date
- NVAX 02-26-2025
- SCS 03-19-2025
- Dividend Yield
- NVAX N/A
- SCS 3.57%
- EPS Growth
- NVAX N/A
- SCS 52.41
- EPS
- NVAX N/A
- SCS 0.96
- Revenue
- NVAX $885,193,000.00
- SCS $3,153,200,000.00
- Revenue This Year
- NVAX N/A
- SCS $0.99
- Revenue Next Year
- NVAX N/A
- SCS $2.19
- P/E Ratio
- NVAX N/A
- SCS $11.67
- Revenue Growth
- NVAX N/A
- SCS N/A
- 52 Week Low
- NVAX $3.60
- SCS $10.90
- 52 Week High
- NVAX $23.86
- SCS $14.74
- Technical
- Relative Strength Index (RSI)
- NVAX 45.04
- SCS 41.65
- Support Level
- NVAX $8.30
- SCS $11.44
- Resistance Level
- NVAX $9.77
- SCS $11.74
- Average True Range (ATR)
- NVAX 0.56
- SCS 0.22
- MACD
- NVAX -0.06
- SCS 0.02
- Stochastic Oscillator
- NVAX 12.67
- SCS 31.71
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands such as Steelcase, AMQ, Coalesse, Designtex, and others offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas which generates key revenue, and International.